Sanofi Asserts 2nd Uroxatral Patent Against Sun

Law360, New York (June 13, 2008, 12:00 AM EDT) -- Sanofi-Aventis has hit Sun Pharmaceutical Industries Ltd. with another patent infringement suit over the drug Uroxatral, alleging that the generics maker infringed another of its patents for the prostate treatment.

The suit, filed Wednesday in the U.S. District Court for the District of Delaware, accuses Sun of infringing U.S. Patent Number 4,661,491, one of two patents that Sanofi has asserted in litigation over the drug Uroxatral.

Sanofi filed suit in September in the same court against Sun and several other generics manufacturers for allegedly infringing U.S....
To view the full article, register now.